Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19

Clinical trial NCT04635943 · COMPLETED

Trial details

NCT number: NCT04635943
Sponsor: Universidad Peruana Cayetano Heredia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Coronavirus Infection SARS-CoV Infection

Start date: 2020-08-29
Primary completion: 2021-04-30
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.